CD160: a unique activating NK cell receptor.
暂无分享,去创建一个
A. Berrebi | P. Le Bouteiller | B. Polgár | A. Bensussan | J. Giustiniani | N. Jabrane-Ferrat | Maryse Aguerre-Girr | Beata Polgar | Armand Bensussan | Philippe Le Bouteiller | Alain Berrebi | Julie Tabiasco | Noemi Kozma | Jérôme Giustiniani | Johan Siewiera | Nabila Jabrane-Ferrat | M. Aguerre‐Girr | J. Tabiasco | Johan Siewiera | N. Kozma
[1] G. Freeman,et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. , 1998, Journal of immunology.
[2] K. Liao,et al. CD5‐low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells , 2008, Journal of leukocyte biology.
[3] N. Stanietsky,et al. Paired NK cell receptors controlling NK cytotoxicity , 2010, FEBS letters.
[4] J. Dausset,et al. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Berrebi,et al. Human decidual NK cells: unique phenotype and functional properties -- a review. , 2006, Placenta.
[6] A. Bensussan,et al. A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity1 , 2007, The Journal of Immunology.
[7] A. Bensussan,et al. Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation1 , 2009, The Journal of Immunology.
[8] G. Leca,et al. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity , 1993, The Journal of experimental medicine.
[9] A. Berrebi,et al. Erratum to “Human Decidual NK Cells: Unique Phenotype and Functional Properties – A Review” [Placenta 27, supplement A, Trophoblast Research, Vol. 20: S34–S39] , 2006 .
[10] A. Berrebi,et al. Critical and Differential Roles of NKp46- and NKp30-Activating Receptors Expressed by Uterine NK Cells in Early Pregnancy1 , 2008, The Journal of Immunology.
[11] K. Campbell,et al. Signal transduction in natural killer cells. , 2006, Current topics in microbiology and immunology.
[12] P. Bouteiller,et al. Killers become builders during pregnancy , 2006, Nature Medicine.
[13] S. Valitutti,et al. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. , 2007, International immunology.
[14] P. Le Bouteiller,et al. Cutting Edge: Engagement of CD160 by its HLA-C Physiological Ligand Triggers a Unique Cytokine Profile Secretion in the Cytotoxic Peripheral Blood NK Cell Subset1 , 2004, The Journal of Immunology.
[15] T. Yamamura,et al. Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation1 , 2005, The Journal of Immunology.
[16] G. Freeman,et al. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation , 2009, Immunological reviews.
[17] M. Bagot,et al. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. , 2007, The Journal of investigative dermatology.
[18] F. Mami-Chouaib,et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] Eric O Long,et al. Activation, coactivation, and costimulation of resting human natural killer cells , 2006, Immunological reviews.
[20] Judith E. Cartwright,et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. , 2006, Blood.
[21] M. Nikolova,et al. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. , 2002, International immunology.
[22] J. Gribben,et al. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. , 2010, Blood.
[23] G. Cai,et al. Corrigendum: CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator , 2008, Nature Immunology.
[24] Y. Obata,et al. Characterization of murine CD160+ CD8+ T lymphocytes. , 2006, Immunology letters.
[25] G. Freeman,et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. , 1999, Journal of immunology.
[26] Lewis L Lanier,et al. Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.
[27] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.